解剖病理追跡ソリューション市場- 世界の産業規模、シェア、動向、機会、予測、用途別、最終用途別、地域別、競合別、2020-2030年

世界の解剖病理追跡ソリューション市場規模は2024年に6億7,392万米ドルで、予測期間中のCAGRは7.48%で2030年には10億4,136万米ドルに達すると予測されています。

世界の解剖病理追跡ソリューション市場は、ヘルスケアおよび医療技術産業の一分野です。組織サンプルや生検材料などの解剖学的病理学的標本の収集から処理、分析、報告までの道のりを追跡・トレースするために高度な技術を使用します。これらのソリューションは、患者の安全性を向上させ、エラーを減らし、病理検査室の効率を高める上で重要な役割を果たしています。

市場促進要因

精密診断に対する需要の高まり

主な市場課題

データプライバシーとセキュリティ

主な市場動向

ブロックチェーンによるセキュリティ強化

目次

第1章 概要

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 顧客の声

第5章 世界の解剖病理追跡ソリューション市場展望

• 市場規模・予測
  • 金額別
• 市場シェア・予測
  • 用途別（スライド追跡、標本追跡、組織カセットおよびブロック追跡）
  • 最終用途別（病院検査室、独立・参照検査室、その他）
  • 地域別
  • 企業別（2024年）
• 市場マップ

第6章 北米の解剖病理追跡ソリューション市場展望

• 市場規模・予測
• 市場シェア・予測
• 北米：国別分析
  • 米国
  • カナダ
  • メキシコ

第7章 欧州の解剖病理追跡ソリューション市場展望

• 市場規模・予測
• 市場シェア・予測
• 欧州：国別分析
  • ドイツ
  • 英国
  • イタリア
  • フランス
  • スペイン

第8章 アジア太平洋地域の解剖病理追跡ソリューション市場展望

• 市場規模・予測
• 市場シェア・予測
• アジア太平洋地域：国別分析
  • 中国
  • インド
  • 日本
  • 韓国
  • オーストラリア

第9章 南米の解剖病理追跡ソリューション市場展望

• 市場規模・予測
• 市場シェア・予測
• 南米：国別分析
  • ブラジル
  • アルゼンチン
  • コロンビア

第10章 中東・アフリカの解剖病理追跡ソリューション市場展望

• 市場規模・予測
• 市場シェア・予測
• 中東・アフリカ：国別分析
  • 南アフリカ
  • サウジアラビア
  • アラブ首長国連邦

第11章 市場力学

• 促進要因
• 課題

第12章 市場動向と発展

• 合併と買収（該当する場合）
• 製品の発売（該当する場合）
• 最近の動向

第13章 ポーターのファイブフォース分析

• 業界内の競合
• 新規参入の可能性
• サプライヤーの力
• 顧客の力
• 代替品の脅威

第14章 競合情勢

• Leica Biosystems Nussloch GmbH
• Thermo Fisher Scientific Inc
• Zebra Technologies Corp.
• Agilent Technologies Inc
• CompuGroup Medical
• LigoLab Information Systems
• General Data Healthcare Inc.
• Psyche Systems Corporation
• Siemens Healthineers AG
• Indica Labs, LLC

第15章 戦略的提言

第16章 調査会社について・免責事項

Global Anatomic Pathology Track & Trace Solution Market was valued at USD 673.92 Million in 2024 and is expected to reach USD 1041.36 Million by 2030 with a CAGR of 7.48% during the forecast period. The Global Anatomic Pathology Track & Trace Solution Market is a segment within the broader healthcare and medical technology industry. It involves the use of advanced technologies to track and trace the journey of anatomical pathology specimens, such as tissue samples and biopsy materials, from collection through processing, analysis, and reporting. These solutions play a crucial role in improving patient safety, reducing errors, and enhancing the efficiency of pathology laboratories.

Key Market Drivers

Rising Demand for Precise Diagnostics

In the ever-advancing realm of healthcare, precision and accuracy in diagnostics are pivotal. Accurate and timely diagnosis not only ensures better patient outcomes but also drives the development of effective treatment plans. The Global Anatomic Pathology Track & Trace Solution Market has emerged as an indispensable player in enhancing the precision of diagnostic processes, and its growth is significantly bolstered by the escalating demand for precise diagnostics.

Key Market Challenges

Data Privacy and Security

In today's digital age, data privacy and security have become paramount concerns, particularly in healthcare environments. The collection, storage, and transfer of sensitive patient information through track and trace solutions present significant risks if not managed correctly. These solutions gather various forms of data, including personal health records, diagnostic results, and treatment histories, all of which must be protected to ensure patient confidentiality. Healthcare institutions are held to stringent regulations, such as HIPAA (Health Insurance Portability and Accountability Act) in the U.S. or GDPR (General Data Protection Regulation) in Europe, that mandate the safeguarding of patient data.

Key Market Trends

Blockchain for Enhanced Security

In the healthcare sector, where data security and privacy are of utmost importance, blockchain technology presents a promising solution to safeguard sensitive patient and diagnostic information. Blockchain's decentralized ledger system provides a high level of security by ensuring that once data is recorded, it cannot be altered or tampered with. This makes blockchain an ideal candidate for enhancing track and trace systems, especially for handling medical records, test results, and specimen data. By leveraging blockchain, healthcare institutions can ensure that all diagnostic data remains authentic and immutable, effectively preventing fraud and reducing the risk of data breaches.

Key Market Players

• Leica Biosystems Nussloch GmbH
• Thermo Fisher Scientific Inc
• Zebra Technologies Corp.
• Agilent Technologies Inc
• CompuGroup Medical
• LigoLab Information Systems
• General Data Healthcare Inc.
• Psyche Systems Corporation
• Siemens Healthineers AG
• Indica Labs, LLC

Report Scope:

In this report, the Global Anatomic Pathology Track & Trace Solution Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Anatomic Pathology Track & Trace Solution Market, By Application:

• Slides Tracking
• Specimen Tracking
• Tissue Cassettes & Blocks Tracking

Anatomic Pathology Track & Trace Solution Market, By End User:

• Hospital Laboratories
• Independent & Reference Laboratories
• Others

Anatomic Pathology Track & Trace Solution Market, By Region:

• North America
  • United States
  • Canada
  • Mexico
• Europe
  • Germany
  • United Kingdom
  • France
  • Italy
  • Spain
• Asia-Pacific
  • China
  • Japan
  • India
  • Australia
  • South Korea
• South America
  • Brazil
  • Argentina
  • Colombia
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Anatomic Pathology Track & Trace Solution Market.

Available Customizations:

Global Anatomic Pathology Track & Trace Solution market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

• 1.1. Market Definition
• 1.2. Scope of the Market
  • 1.2.1. Markets Covered
  • 1.2.2. Years Considered for Study
  • 1.2.3. Key Market Segmentations

2. Research Methodology

• 2.1. Objective of the Study
• 2.2. Baseline Methodology
• 2.3. Key Industry Partners
• 2.4. Major Association and Secondary Sources
• 2.5. Forecasting Methodology
• 2.6. Data Triangulation & Validations
• 2.7. Assumptions and Limitations

3. Executive Summary

• 3.1. Overview of the Market
• 3.2. Overview of Key Market Segmentations
• 3.3. Overview of Key Market Players
• 3.4. Overview of Key Regions/Countries
• 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Anatomic Pathology Track & Trace Solution Market Outlook

• 5.1. Market Size & Forecast
  • 5.1.1. By Value
• 5.2. Market Share & Forecast
  • 5.2.1. By Application (Slides Tracking, Specimen Tracking, Tissue Cassettes & Blocks Tracking)
  • 5.2.2. By End User (Hospital Laboratories, Independent & Reference Laboratories, Others)
  • 5.2.3. By Region
  • 5.2.4. By Company (2024)
• 5.3. Market Map

6. North America Anatomic Pathology Track & Trace Solution Market Outlook

• 6.1. Market Size & Forecast
  • 6.1.1. By Value
• 6.2. Market Share & Forecast
  • 6.2.1. By Application
  • 6.2.2. By End User
  • 6.2.3. By Country
• 6.3. North America: Country Analysis
  • 6.3.1. United States Anatomic Pathology Track & Trace Solution Market Outlook
    • 6.3.1.1. Market Size & Forecast
      • 6.3.1.1.1. By Value
    • 6.3.1.2. Market Share & Forecast
      • 6.3.1.2.1. By Application
      • 6.3.1.2.2. By End User
  • 6.3.2. Canada Anatomic Pathology Track & Trace Solution Market Outlook
    • 6.3.2.1. Market Size & Forecast
      • 6.3.2.1.1. By Value
    • 6.3.2.2. Market Share & Forecast
      • 6.3.2.2.1. By Application
      • 6.3.2.2.2. By End User
  • 6.3.3. Mexico Anatomic Pathology Track & Trace Solution Market Outlook
    • 6.3.3.1. Market Size & Forecast
      • 6.3.3.1.1. By Value
    • 6.3.3.2. Market Share & Forecast
      • 6.3.3.2.1. By Application
      • 6.3.3.2.2. By End User

7. Europe Anatomic Pathology Track & Trace Solution Market Outlook

• 7.1. Market Size & Forecast
  • 7.1.1. By Value
• 7.2. Market Share & Forecast
  • 7.2.1. By Application
  • 7.2.2. By End User
  • 7.2.3. By Country
• 7.3. Europe: Country Analysis
  • 7.3.1. Germany Anatomic Pathology Track & Trace Solution Market Outlook
    • 7.3.1.1. Market Size & Forecast
      • 7.3.1.1.1. By Value
    • 7.3.1.2. Market Share & Forecast
      • 7.3.1.2.1. By Application
      • 7.3.1.2.2. By End User
  • 7.3.2. United Kingdom Anatomic Pathology Track & Trace Solution Market Outlook
    • 7.3.2.1. Market Size & Forecast
      • 7.3.2.1.1. By Value
    • 7.3.2.2. Market Share & Forecast
      • 7.3.2.2.1. By Application
      • 7.3.2.2.2. By End User
  • 7.3.3. Italy Anatomic Pathology Track & Trace Solution Market Outlook
    • 7.3.3.1. Market Size & Forecast
      • 7.3.3.1.1. By Value
    • 7.3.3.2. Market Share & Forecast
      • 7.3.3.2.1. By Application
      • 7.3.3.2.2. By End User
  • 7.3.4. France Anatomic Pathology Track & Trace Solution Market Outlook
    • 7.3.4.1. Market Size & Forecast
      • 7.3.4.1.1. By Value
    • 7.3.4.2. Market Share & Forecast
      • 7.3.4.2.1. By Application
      • 7.3.4.2.2. By End User
  • 7.3.5. Spain Anatomic Pathology Track & Trace Solution Market Outlook
    • 7.3.5.1. Market Size & Forecast
      • 7.3.5.1.1. By Value
    • 7.3.5.2. Market Share & Forecast
      • 7.3.5.2.1. By Application
      • 7.3.5.2.2. By End User

8. Asia-Pacific Anatomic Pathology Track & Trace Solution Market Outlook

• 8.1. Market Size & Forecast
  • 8.1.1. By Value
• 8.2. Market Share & Forecast
  • 8.2.1. By Application
  • 8.2.2. By End User
  • 8.2.3. By Country
• 8.3. Asia-Pacific: Country Analysis
  • 8.3.1. China Anatomic Pathology Track & Trace Solution Market Outlook
    • 8.3.1.1. Market Size & Forecast
      • 8.3.1.1.1. By Value
    • 8.3.1.2. Market Share & Forecast
      • 8.3.1.2.1. By Application
      • 8.3.1.2.2. By End User
  • 8.3.2. India Anatomic Pathology Track & Trace Solution Market Outlook
    • 8.3.2.1. Market Size & Forecast
      • 8.3.2.1.1. By Value
    • 8.3.2.2. Market Share & Forecast
      • 8.3.2.2.1. By Application
      • 8.3.2.2.2. By End User
  • 8.3.3. Japan Anatomic Pathology Track & Trace Solution Market Outlook
    • 8.3.3.1. Market Size & Forecast
      • 8.3.3.1.1. By Value
    • 8.3.3.2. Market Share & Forecast
      • 8.3.3.2.1. By Application
      • 8.3.3.2.2. By End User
  • 8.3.4. South Korea Anatomic Pathology Track & Trace Solution Market Outlook
    • 8.3.4.1. Market Size & Forecast
      • 8.3.4.1.1. By Value
    • 8.3.4.2. Market Share & Forecast
      • 8.3.4.2.1. By Application
      • 8.3.4.2.2. By End User
  • 8.3.5. Australia Anatomic Pathology Track & Trace Solution Market Outlook
    • 8.3.5.1. Market Size & Forecast
      • 8.3.5.1.1. By Value
    • 8.3.5.2. Market Share & Forecast
      • 8.3.5.2.1. By Application
      • 8.3.5.2.2. By End User

9. South America Anatomic Pathology Track & Trace Solution Market Outlook

• 9.1. Market Size & Forecast
  • 9.1.1. By Value
• 9.2. Market Share & Forecast
  • 9.2.1. By Application
  • 9.2.2. By End User
  • 9.2.3. By Country
• 9.3. South America: Country Analysis
  • 9.3.1. Brazil Anatomic Pathology Track & Trace Solution Market Outlook
    • 9.3.1.1. Market Size & Forecast
      • 9.3.1.1.1. By Value
    • 9.3.1.2. Market Share & Forecast
      • 9.3.1.2.1. By Application
      • 9.3.1.2.2. By End User
  • 9.3.2. Argentina Anatomic Pathology Track & Trace Solution Market Outlook
    • 9.3.2.1. Market Size & Forecast
      • 9.3.2.1.1. By Value
    • 9.3.2.2. Market Share & Forecast
      • 9.3.2.2.1. By Application
      • 9.3.2.2.2. By End User
  • 9.3.3. Colombia Anatomic Pathology Track & Trace Solution Market Outlook
    • 9.3.3.1. Market Size & Forecast
      • 9.3.3.1.1. By Value
    • 9.3.3.2. Market Share & Forecast
      • 9.3.3.2.1. By Application
      • 9.3.3.2.2. By End User

10. Middle East and Africa Anatomic Pathology Track & Trace Solution Market Outlook

• 10.1. Market Size & Forecast
  • 10.1.1. By Value
• 10.2. Market Share & Forecast
  • 10.2.1. By Application
  • 10.2.2. By End User
  • 10.2.3. By Country
• 10.3. MEA: Country Analysis
  • 10.3.1. South Africa Anatomic Pathology Track & Trace Solution Market Outlook
    • 10.3.1.1. Market Size & Forecast
      • 10.3.1.1.1. By Value
    • 10.3.1.2. Market Share & Forecast
      • 10.3.1.2.1. By Application
      • 10.3.1.2.2. By End User
  • 10.3.2. Saudi Arabia Anatomic Pathology Track & Trace Solution Market Outlook
    • 10.3.2.1. Market Size & Forecast
      • 10.3.2.1.1. By Value
    • 10.3.2.2. Market Share & Forecast
      • 10.3.2.2.1. By Application
      • 10.3.2.2.2. By End User
  • 10.3.3. UAE Anatomic Pathology Track & Trace Solution Market Outlook
    • 10.3.3.1. Market Size & Forecast
      • 10.3.3.1.1. By Value
    • 10.3.3.2. Market Share & Forecast
      • 10.3.3.2.1. By Application
      • 10.3.3.2.2. By End User

11. Market Dynamics

• 11.1. Drivers
• 11.2. Challenges

12. Market Trends & Developments

• 12.1. Merger & Acquisition (If Any)
• 12.2. Product Launches (If Any)
• 12.3. Recent Developments

13. Porter's Five Forces Analysis

• 13.1. Competition in the Industry
• 13.2. Potential of New Entrants
• 13.3. Power of Suppliers
• 13.4. Power of Customers
• 13.5. Threat of Substitute Products

14. Competitive Landscape

• 14.1. Leica Biosystems Nussloch GmbH
  • 14.1.1. Business Overview
  • 14.1.2. Company Snapshot
  • 14.1.3. Products & Services
  • 14.1.4. Financials (As Reported)
  • 14.1.5. Recent Developments
  • 14.1.6. Key Personnel Details
  • 14.1.7. SWOT Analysis
• 14.2. Thermo Fisher Scientific Inc
• 14.3. Zebra Technologies Corp.
• 14.4. Agilent Technologies Inc
• 14.5. CompuGroup Medical
• 14.6. LigoLab Information Systems
• 14.7. General Data Healthcare Inc.
• 14.8. Psyche Systems Corporation
• 14.9. Siemens Healthineers AG
• 14.10. Indica Labs, LLC

15. Strategic Recommendations

16. About Us & Disclaimer